# Cellectar Biosciences, Inc.: Form DEF 14A, filed May 28, 2026

- Company: [Cellectar Biosciences, Inc.](/companies/clrb.md) (CIK 1279704)
- Form: DEF 14A
- Filed: 2026-05-28
- Accepted by EDGAR: May 28, 2026, 17:13 ET
- Period: 2026-07-07
- Accession: 0001104659-26-067626
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1279704/000110465926067626/tm261621d4_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1279704/000110465926067626/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1279704/000110465926067626/tm261621d4_def14a.htm

Filed May 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-067626. Last ingested by Listed: Nov 10, 2026, 16:55 ET. No prices; not investment advice.
